WATERS CORP /DE/ - Quarter Report: 2011 April (Form 10-Q)

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-Q

þ		QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

o		TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission File Number: 01-14010

Waters Corporation

(Exact name of registrant as specified in its charter)

Delaware		13-3668640
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

34 Maple Street
Milford, Massachusetts 01757
(Address, including zip code, of principal executive offices)

(508) 478-2000
(Registrant’s telephone number, including area code)

     Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes þ No o

     Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). þ Yes o No

     Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer þ		Accelerated filer o		Non-accelerated filer o		Smaller reporting company o
				(Do not check if smaller reporting company)

     Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes o No þ

     Indicate the number of shares outstanding of the registrant’s common stock as of April 29, 2011: 91,638,667

 

 

WATERS CORPORATION AND SUBSIDIARIES

QUARTERLY REPORT ON FORM 10-Q

INDEX

		Page
PART I FINANCIAL INFORMATION
Item 1. Financial Statements
Consolidated Balance Sheets (unaudited) as of April 2, 2011 and December 31, 2010			1
Consolidated Statements of Operations (unaudited) for the three months ended April 2, 2011 and April 3, 2010			2
Consolidated Statements of Cash Flows (unaudited) for the three months ended April 2, 2011 and April 3, 2010			3
Condensed Notes to Consolidated Financial Statements (unaudited)			4
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations			15
Item 3. Quantitative and Qualitative Disclosures About Market Risk			20
Item 4. Controls and Procedures			20
PART II OTHER INFORMATION
Item 1. Legal Proceedings			21
Item 1A. Risk Factors			21
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds			21
Item 6. Exhibits			22
Signature			23
EX-10.62
EX-10.63
EX-31.1
EX-31.2
EX-32.1
EX-32.2
EX-101 INSTANCE DOCUMENT
EX-101 SCHEMA DOCUMENT
EX-101 CALCULATION LINKBASE DOCUMENT
EX-101 LABELS LINKBASE DOCUMENT
EX-101 PRESENTATION LINKBASE DOCUMENT
EX-101 DEFINITION LINKBASE DOCUMENT

WATERS CORPORATION AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(IN THOUSANDS, EXCEPT PER SHARE DATA)
(unaudited)

		April 2, 2011				December 31, 2010
ASSETS
Current assets:
Cash and cash equivalents		$	296,860			$	308,498
Short-term investments			742,189				637,921
Accounts receivable, less allowances for doubtful accounts and sales returns of $7,844 and $6,196 at April 2, 2011 and December 31, 2010, respectively			349,397				358,237
Inventories			223,882				204,300
Other current assets			71,006				77,685
Total current assets			1,683,334				1,586,641
Property, plant and equipment, net			216,989				215,060
Intangible assets, net			191,432				181,316
Goodwill			293,517				291,657
Other assets			61,890				52,996
Total assets		$	2,447,162			$	2,327,670
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Notes payable and debt		$	390,346			$	66,055
Accounts payable			67,404				64,406
Accrued employee compensation			28,669				52,831
Deferred revenue and customer advances			133,781				106,445
Accrued income taxes			23,132				11,909
Accrued warranty			11,934				11,272
Other current liabilities			60,963				72,932
Total current liabilities			716,229				385,850
Long-term liabilities:
Long-term debt			400,000				700,000
Long-term portion of retirement benefits			75,742				72,624
Long-term income tax liability			78,855				77,764
Other long-term liabilities			25,542				22,635
Total long-term liabilities			580,139				873,023
Total liabilities			1,296,368				1,258,873
Commitments and contingencies (Notes 4, 5 and 9)
Stockholders’ equity:
Preferred stock, par value $0.01 per share, 5,000 shares authorized, none issued at April 2, 2011 and December 31, 2010			—				—
Common stock, par value $0.01 per share, 400,000 shares authorized, 151,661 and 151,054 shares issued, 91,532 and 91,848 shares outstanding at April 2, 2011 and December 31, 2010, respectively			1,517				1,511
Additional paid-in capital			996,675				970,068
Retained earnings			2,712,968				2,618,479
Treasury stock, at cost, 60,129 and 59,206 shares at April 2, 2011 and December 31, 2010, respectively			(2,582,645	)			(2,509,466	)
Accumulated other comprehensive income (loss)			22,279				(11,795	)
Total stockholders’ equity			1,150,794				1,068,797
Total liabilities and stockholders’ equity		$	2,447,162			$	2,327,670

The accompanying notes are an integral part of the interim consolidated financial statements.

WATERS CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
(IN THOUSANDS, EXCEPT PER SHARE DATA)
(unaudited)

		Three Months Ended
		April 2, 2011				April 3, 2010
Product sales		$	303,336			$	253,042
Service sales			124,267				114,658
Total net sales			427,603				367,700
Cost of product sales			115,901				97,405
Cost of service sales			53,928				48,527
Total cost of sales			169,829				145,932
Gross profit			257,774				221,768
Selling and administrative expenses			117,124				106,693
Research and development expenses			22,254				20,076
Purchased intangibles amortization			2,501				2,642
Operating income			115,895				92,357
Interest expense			(4,083	)			(2,614	)
Interest income			713				329
Income from operations before income taxes			112,525				90,072
Provision for income taxes			18,036				14,554
Net income		$	94,489			$	75,518
Net income per basic common share		$	1.03			$	0.81
Weighted-average number of basic common shares			91,649				93,629
Net income per diluted common share		$	1.01			$	0.79
Weighted-average number of diluted common shares and equivalents			93,313				95,223

The accompanying notes are an integral part of the interim consolidated financial statements.

WATERS CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS
(IN THOUSANDS)
(unaudited)

		Three Months Ended
		April 2, 2011				April 3, 2010
Cash flows from operating activities:
Net income		$	94,489			$	75,518
Adjustments to reconcile net income to net cash provided by operating activities:
Provisions for doubtful accounts on accounts receivable			1,022				904
Provisions on inventory			3,224				2,648
Stock-based compensation			7,015				6,031
Deferred income taxes			(1,479	)			(1,950	)
Depreciation			8,640				8,441
Amortization of intangibles			7,520				6,544
Change in operating assets and liabilities, net of acquisitions:
Decrease (increase) in accounts receivable			17,730				(6,230	)
Increase in inventories			(17,353	)			(16,134	)
Decrease (increase) in other current assets			2,278				(4,679	)
Increase in other assets			(1,755	)			(4,222	)
(Decrease) increase in accounts payable and other current liabilities			(26,836	)			13,720
Increase in deferred revenue and customer advances			23,856				23,732
Increase (decrease) in other liabilities			4,410				(1,168	)
Net cash provided by operating activities			122,761				103,155
Cash flows from investing activities:
Additions to property, plant, equipment and software capitalization			(16,839	)			(10,165	)
Purchase of short-term investments			(432,189	)			(216,748	)
Maturity of short-term investments			327,921				110,726
Net cash used in investing activities			(121,107	)			(116,187	)
Cash flows from financing activities:
Proceeds from debt issuances			242,126				213,273
Payments on debt			(217,835	)			(132,663	)
Payments of debt issuance costs			(1,169	)			(1,473	)
Proceeds from stock plans			14,083				8,852
Purchase of treasury shares			(73,179	)			(105,019	)
Excess tax benefit related to stock option plans			5,832				2,182
Proceeds from (payments for) debt swaps and other derivative contracts			2,892				(3,631	)
Net cash used in financing activities			(27,250	)			(18,479	)
Effect of exchange rate changes on cash and cash equivalents			13,958				(12,588	)
Decrease in cash and cash equivalents			(11,638	)			(44,099	)
Cash and cash equivalents at beginning of period			308,498				341,111
Cash and cash equivalents at end of period		$	296,860			$	297,012

The accompanying notes are an integral part of the interim consolidated financial statements.

WATERS CORPORATION AND SUBSIDIARIES

1 Basis of Presentation and Summary of Significant Accounting Policies

Waters Corporation (“Waters^®” or the “Company”), an analytical instrument manufacturer, primarily designs, manufactures, sells and services, through its Waters Division, high performance liquid chromatography (“HPLC”), ultra performance liquid chromatography (“UPLC^®” and together with HPLC, referred to as “LC”) and mass spectrometry (“MS”) instrument systems and support products, including chromatography columns, other consumable products and comprehensive post-warranty service plans. These systems are complementary products that can be integrated together and used along with other analytical instruments. LC is a standard technique and is utilized in a broad range of industries to detect, identify, monitor and measure the chemical, physical and biological composition of materials, and to purify a full range of compounds. MS instruments are used in drug discovery and development, including clinical trial testing, the analysis of proteins in disease processes (known as “proteomics”), food safety analysis and environmental testing. LC is often combined with MS to create LC-MS instruments that include a liquid phase sample introduction and separation system with mass spectrometric compound identification and quantification. Through its TA Division (“TA^®”), the Company primarily designs, manufactures, sells and services thermal analysis, rheometry and calorimetry instruments, which are used in predicting the suitability of fine chemicals, polymers and viscous liquids for various industrial, consumer goods and healthcare products, as well as for life science research. The Company is also a developer and supplier of software-based products that interface with the Company’s instruments and are typically purchased by customers as part of the instrument system.

The Company’s interim fiscal quarter typically ends on the thirteenth Saturday of each quarter. Since the Company’s fiscal year end is December 31, the first and fourth fiscal quarters will not consist of thirteen complete weeks. The Company’s first fiscal quarters for 2011 and 2010 ended on April 2, 2011 and April 3, 2010, respectively.

The accompanying unaudited interim consolidated financial statements have been prepared in accordance with the instructions to Form 10-Q and do not include all of the information and note disclosures required by generally accepted accounting principles (“GAAP”) in the United States of America. The consolidated financial statements include the accounts of the Company and its subsidiaries, most of which are wholly owned. All material inter-company balances and transactions have been eliminated.

The preparation of consolidated financial statements in conformity with GAAP requires the Company to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent liabilities at the dates of the financial statements. Actual amounts may differ from these estimates under different assumptions or conditions.

It is management’s opinion that the accompanying interim consolidated financial statements reflect all adjustments (which are normal and recurring) that are necessary for a fair statement of the results for the interim periods. The interim consolidated financial statements should be read in conjunction with the consolidated financial statements included in the Company’s annual report on Form 10-K for the year ended December 31, 2010, as filed with the Securities and Exchange Commission on February 25, 2011.

Fair Value Measurements

In accordance with the accounting standards for fair value measurements and disclosures, certain of the Company’s assets and liabilities are measured at fair value on a recurring basis as of April 2, 2011 and December 31, 2010. Fair values determined by Level 1 inputs utilize observable data, such as quoted prices in active markets. Fair values determined by Level 2 inputs utilize data points other than quoted prices in active markets that are observable either directly or indirectly. Fair values determined by Level 3 inputs utilize unobservable data points for which there is little or no market data, which require the reporting entity to develop its own assumptions.

CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

The following table represents the Company’s assets and liabilities measured at fair value on a recurring basis at April 2, 2011 (in thousands):

						Quoted Prices
						in Active				Significant
						Markets				Other				Significant
						for Identical				Observable				Unobservable
		Total at				Assets				Inputs				Inputs
		April 2, 2011				(Level 1)				(Level 2)				(Level 3)
Assets:
Cash equivalents		$	96,753			$	—			$	96,753			$	—
Short-term investments			742,189				—				742,189				—
Waters 401(k) Restoration Plan assets			21,850				—				21,850				—
Foreign currency exchange contract agreements			987				—				987				—
Total		$	861,779			$	—			$	861,779			$	—
Liabilities:
Foreign currency exchange contract agreements		$	283			$	—			$	283			$	—
Total		$	283			$	—			$	283			$	—

The following table represents the Company’s assets and liabilities measured at fair value on a recurring basis at December 31, 2010 (in thousands):

						Quoted Prices
						in Active				Significant
						Markets				Other				Significant
		Total at				for Identical				Observable				Unobservable
		December 31,				Assets				Inputs				Inputs
		2010				(Level 1)				(Level 2)				(Level 3)
Assets:
Cash equivalents		$	87,975			$	—			$	87,975			$	—
Short-term investments			637,921				—				637,921				—
Waters 401(k) Restoration Plan assets			19,988				—				19,988				—
Foreign currency exchange contract agreements			424				—				424				—
Total		$	746,308			$	—			$	746,308			$	—
Liabilities:
Foreign currency exchange contract agreements		$	626			$	—			$	626			$	—
Total		$	626			$	—			$	626			$	—

The Company’s financial assets and liabilities have been classified as Level 2. These assets and liabilities have been initially valued at the transaction price and subsequently valued, typically utilizing third-party pricing services. The pricing services use many inputs to determine value, including reportable trades, benchmark yields, credit spreads, broker/dealer quotes, current spot rates and other industry and economic events. The Company validates the prices provided by third-party pricing services by reviewing their pricing methods and obtaining market values from other pricing sources. The fair values of the Company’s cash equivalents, short-term investments, 401(k) restoration plan assets and foreign currency exchange contracts are determined through market and observable sources and have been classified as Level 2. After completing these validation procedures, the Company did not adjust or override any fair value measurements provided by third-party pricing services as of April 2, 2011 and December 31, 2010.

CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

Fair Value of Other Financial Instruments

The Company’s cash, accounts receivable, accounts payable and debt are recorded at cost, which approximates fair value. The carrying value and fair value of the Company’s fixed interest rate debt is $400 million and $388 million, respectively, at April 2, 2011. The carrying value and fair value of the Company’s fixed interest rate debt is $200 million and $203 million, respectively, at December 31, 2010.

Hedge Transactions

The Company operates on a global basis and is exposed to the risk that its earnings, cash flows and stockholders’ equity could be adversely impacted by fluctuations in currency exchange rates and interest rates.

The Company records its hedge transactions in accordance with the accounting standards for derivative instruments and hedging activities, which establishes the accounting and reporting standards for derivative instruments, including certain derivative instruments embedded in other contracts, and for hedging activities. All derivatives, whether designated in hedging relationships or not, are required to be recorded on the consolidated balance sheets at fair value as either assets or liabilities. If the derivative is designated as a fair-value hedge, the changes in the fair value of the derivative and of the hedged item attributable to the hedged risk are recognized in earnings. If the derivative is designated as a cash flow hedge, the effective portions of changes in the fair value of the derivative are recorded in other comprehensive income and are recognized in earnings when the hedged item affects earnings; ineffective portions of changes in fair value are recognized in earnings. In addition, disclosures required for derivative instruments and hedging activities include the Company’s objectives for using derivative instruments, the level of derivative activity the Company engages in, as well as how derivative instruments and related hedged items affect the Company’s financial position and performance.

The Company currently uses derivative instruments to manage exposures to foreign currency and interest rate risks. The Company’s objectives for holding derivatives are to minimize foreign currency and interest rate risk using the most effective methods to eliminate or reduce the impact of foreign currency and interest rate exposures. The Company documents all relationships between hedging instruments and hedged items and links all derivatives designated as fair-value, cash flow or net investment hedges to specific assets and liabilities on the consolidated balance sheets or to specific forecasted transactions. In addition, the Company considers the impact of its counterparties’ credit risk on the fair value of the contracts as well as the ability of each party to execute under the contracts. The Company also assesses and documents, both at the hedges’ inception and on an ongoing basis, whether the derivatives that are used in hedging transactions are highly effective in offsetting changes in fair values or cash flows associated with the hedged items.

The Company enters into forward foreign exchange contracts, principally to hedge the impact of currency fluctuations on certain inter-company balances and short-term assets and liabilities. Principal hedged currencies include the Euro, Japanese Yen, British Pound and Singapore Dollar. The periods of these forward contracts typically range from one to three months and have varying notional amounts, which are intended to be consistent with changes in the underlying exposures. Gains and losses on these forward contracts are recorded in selling and administrative expenses in the consolidated statements of operations. At April 2, 2011 and December 31, 2010, the Company held forward foreign exchange contracts with notional amounts totaling $148 million and $136 million, respectively. At April 2, 2011 and December 31, 2010, the Company had assets of $1 million and less than $1 million, respectively, in other current assets in the consolidated balance sheets related to the foreign currency exchange contracts. At April 2, 2011 and December 31, 2010, the Company had liabilities of less than $1 million and $1 million, respectively, in other current liabilities in the consolidated balance sheets related to the foreign currency exchange contracts. For the three months ended April 2, 2011, the Company recorded cumulative net pre-tax gains of $4 million, which consists of realized gains of $3 million relating to closed forward contracts and $1 million of unrealized gains relating to open forward contracts. For the three months ended April 3, 2010, the Company recorded cumulative net pre-tax losses of $2 million, which consists of realized losses of $4 million relating to closed forward contracts and $2 million of unrealized gains relating to open forward contracts.

Stockholders’ Equity

The Company repurchased $67 million and $101 million of the Company’s outstanding common stock during the three months ended April 2, 2011 and April 3, 2010, respectively. In February 2011, the Company’s Board of Directors authorized the Company to repurchase up to $500 million of its outstanding common stock over a two-year period. During the three months ended April 2, 2011, the Company repurchased 0.2 million shares at a cost of $17 million under this program.

CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

In February 2009, the Company’s Board of Directors authorized the Company to repurchase up to $500 million of its outstanding common stock over a two-year period. During the three months ended April 2, 2011 and April 3, 2010, the Company repurchased 0.7 million and 1.7 million shares at a cost of $50 million and $101 million, respectively, under this program. As of April 2, 2011, the Company repurchased an aggregate of 8.2 million shares of its common stock under the now expired February 2009 program for an aggregate cost of $499 million.

Product Warranty Costs

The Company accrues estimated product warranty costs at the time of sale, which are included in cost of sales in the consolidated statements of operations. While the Company engages in extensive product quality programs and processes, including actively monitoring and evaluating the quality of its component supplies, the Company’s warranty obligation is affected by product failure rates, material usage and service delivery costs incurred in correcting a product failure. The amount of the accrued warranty liability is based on historical information, such as past experience, product failure rates, number of units repaired and estimated costs of material and labor. The liability is reviewed for reasonableness at least quarterly.

The following is a summary of the activity of the Company’s accrued warranty liability for the three months ended April 2, 2011 and April 3, 2010 (in thousands):

		Balance at												Balance at
		Beginning				Accruals for				Settlements				End of
		of Period				Warranties				Made				Period
Accrued warranty liability:
April 2, 2011		$	11,272			$	2,603			$	(1,941	)		$	11,934
April 3, 2010		$	10,109			$	1,409			$	(1,476	)		$	10,042

Subsequent Events

The Company did not have any material subsequent events.

2 Inventories

Inventories are classified as follows (in thousands):

		April 2, 2011				December 31, 2010
Raw materials		$	72,077			$	63,475
Work in progress			20,878				17,301
Finished goods			130,927				123,524
Total inventories		$	223,882			$	204,300

3 Goodwill and Other Intangibles

The carrying amount of goodwill was $294 million and $292 million at April 2, 2011 and December 31, 2010, respectively. Currency translation adjustments increased goodwill by $2 million.

CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

The Company’s intangible assets included in the consolidated balance sheets are detailed as follows (in thousands):

		April 2, 2011												December 31, 2010
										Weighted-												Weighted-
		Gross								Average				Gross								Average
		Carrying				Accumulated				Amortization				Carrying				Accumulated				Amortization
		Amount				Amortization				Period				Amount				Amortization				Period
Purchased intangibles		$	136,270			$	74,460			10 years				$	134,723			$	70,832			10 years
Capitalized software			253,481				139,826			5 years					229,850				127,056			5 years
Licenses			6,619				5,803			6 years					9,877				8,971			7 years
Patents and other intangibles			31,333				16,182			8 years					28,931				15,206			8 years
Total		$	427,703			$	236,271			7 years				$	403,381			$	222,065			7 years

The gross carrying value of intangible assets and accumulated amortization for intangible assets increased by $17 million and $10 million, respectively, in the three months ended April 2, 2011 due to the effect of foreign currency translation. Amortization expense for intangible assets was $8 million and $7 million for the three months ended April 2, 2011 and April 3, 2010, respectively. Amortization expense for intangible assets is estimated to be approximately $40 million per year for 2012 and 2013 and is estimated to increase to approximately $45 million per year for the years 2014 through 2016.

4 Debt

The Company issued and sold the following senior unsecured notes during the three months ended April 2, 2011:

Face Value

Senior Notes

Issue Date

Term

Interest Rate

(in millions)

Maturity Date

Series C

March 2011

5 years

2.50

%

$

50

March 2016

Series D

March 2011

7 years

3.22

%

$

100

March 2018

Series E

March 2011

10 years

3.97

%

$

50

March 2021

The Company used the proceeds from the issuance of these senior unsecured notes to repay $140 million of the term loan under the 2007 Credit Agreement and other outstanding debt, and for general corporate purposes. Interest on the issuances of senior unsecured notes is payable semi-annually in March and September of each year. The Company may prepay all or some of the senior notes at any time in an amount not less than 10% of the aggregate principal amount outstanding, plus the applicable make-whole amount. In the event of a change in control (as defined in the note purchase agreements) of the Company, the Company may be required to prepay the senior notes at a price equal to 100% of the principal amount thereof, plus accrued and unpaid interest. These notes require that the Company comply with an interest coverage ratio test of not less than 3.50:1 and a leverage ratio test of not more than 3.50:1 for any period of four consecutive fiscal quarters, respectively. In addition, these notes include customary negative covenants, certain customary representations and warranties, affirmative covenants and events of default.

In January 2007, the Company entered into a credit agreement (the “2007 Credit Agreement”) that provides for a $500 million term loan facility and $600 million in revolving facilities, which include both a letter of credit and a swingline subfacility. The 2007 Credit Agreement matures in January 2012 and requires no scheduled prepayments before that date. The interest rates applicable to the 2007 Credit Agreement are, at the Company’s option, equal to either the base rate (which is the higher of the prime rate or the federal funds rate plus 1/2%) or the applicable 1, 2, 3, 6, 9 or 12 month LIBOR rate, in each case plus a credit margin based upon the Company’s leverage ratio, which can range between 33 basis points and 72.5 basis points for LIBOR rate loans and range between zero basis points and 37.5 basis points for base rate loans. The 2007 Credit Agreement requires that the Company comply with an interest coverage ratio test of not less than 3.50:1 and a leverage ratio test of not more than 3.25:1 for any period of four consecutive fiscal quarters, respectively. In addition, the 2007 Credit Agreement includes negative covenants that are customary for investment grade credit facilities and customary representations and warranties, affirmative covenants and events of default.

CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

As of April 2, 2011, the Company was in compliance with all debt covenants.

At April 2, 2011 and December 31, 2010, the Company had the following outstanding debt (in thousands):

		April 2, 2011				December 31, 2010
Lines of credit		$	10,346			$	11,055
2007 Credit Agreement, due January 2012			380,000				55,000
Total notes payable and debt			390,346				66,055
Senior unsecured notes — Series A — 3.75%, due February 2015			100,000				100,000
Senior unsecured notes — Series B — 5.00%, due February 2020			100,000				100,000
Senior unsecured notes — Series C — 2.50%, due March 2016			50,000				—
Senior unsecured notes — Series D — 3.22%, due March 2018			100,000				—
Senior unsecured notes — Series E — 3.97%, due March 2021			50,000				—
2007 Credit Agreement, due January 2012			—				500,000
Total long-term debt			400,000				700,000
Total debt		$	790,346			$	766,055

As of April 2, 2011 and December 31, 2010, the Company had a total amount available to borrow of $579 million and $543 million, respectively, after outstanding letters of credit. The weighted-average interest rates applicable to the senior notes and 2007 Credit Agreement borrowings were 2.30% and 1.69% at April 2, 2011 and December 31, 2010, respectively. The increase in the weighted-average interest rate for the Company’s long-term debt is primarily due to a higher rate paid on the fixed-rate debt.

The Company and its foreign subsidiaries also had available short-term lines of credit totaling $102 million and $111 million at April 2, 2011 and December 31, 2010, respectively, for the purpose of short-term borrowing and issuance of commercial guarantees. At April 2, 2011 and December 31, 2010, the weighted-average interest rates applicable to the short-term borrowings were 2.11% and 2.10%, respectively.

5 Income Taxes

The Company accounts for its uncertain tax return reporting positions in accordance with the accounting standards for income taxes, which require financial statement reporting of the expected future tax consequences of uncertain tax reporting positions on the presumption that all concerned tax authorities possess full knowledge of the reporting positions, as well as all of the pertinent facts and circumstances, but prohibit any discounting of unrecognized tax benefits associated with uncertain reporting positions for the time value of money.

The following is a summary of the activity in the Company’s unrecognized tax benefits for the three months ended April 2, 2011 and April 3, 2010 (in thousands):

		April 2, 2011				April 3, 2010
Balance at the beginning of the period		$	71,523			$	77,924
Realization of uncertain pre-acquisition tax benefits			—				(1,500	)
Increase in other uncertain tax benefits			1,374				1,052
Balance at the end of the period		$	72,897			$	77,476

For the three months ended April 3, 2010, the Company recorded approximately $2 million of tax benefit in the income tax provision related to the resolution of a pre-acquisition tax exposure. The Company’s uncertain tax positions are taken with respect to income tax return reporting periods beginning after December 31, 1999, which are the periods that generally remain open to income tax audit examination by the concerned income tax authorities. The Company continuously monitors the lapsing of statutes of limitations on potential tax assessments for related changes in the measurement of unrecognized tax benefits, related net interest and penalties, and deferred tax assets and liabilities. As of April 2, 2011, the Company does not expect to record any material changes in the measurement of any other unrecognized tax benefits, related net interest and penalties or deferred tax assets and liabilities due to

CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

the settlement of tax audit examinations or to the lapsing of statutes of limitations on potential tax assessments within the next twelve months.

The Company’s effective tax rates for the three months ended April 2, 2011 and April 3, 2010 were 16.0% and 16.2%, respectively. Included in the income tax provision for the three months ended April 3, 2010 is the aforementioned $2 million of tax benefit related to the resolution of a pre-acquisition tax exposure. This tax benefit decreased the Company’s effective tax rate by 1.7 percentage points in the three months ended April 3, 2010. The remaining difference between the effective tax rates for the three months ended April 2, 2011 as compared to the three months ended April 3, 2010 was primarily attributable to differences in the proportionate amounts of pre-tax income recognized in jurisdictions with different effective tax rates.

6 Stock-Based Compensation

The Company maintains various shareholder-approved, stock-based compensation plans which allow for the issuance of incentive or non-qualified stock options, stock appreciation rights, restricted stock or other types of awards (e.g. restricted stock units).

The Company accounts for stock-based compensation costs in accordance with the accounting standards for stock-based compensation, which require that all share-based payments to employees be recognized in the statements of operations based on their fair values. The Company recognizes the expense using the straight-line attribution method. The stock-based compensation expense recognized in the consolidated statements of operations is based on awards that ultimately are expected to vest; therefore, the amount of expense has been reduced for estimated forfeitures. The stock-based compensation accounting standards require forfeitures to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. Forfeitures were estimated based on historical experience. If actual results differ significantly from these estimates, stock-based compensation expense and the Company’s results of operations could be materially impacted. In addition, if the Company employs different assumptions in the application of this standard, the compensation expense that the Company records in the future periods may differ significantly from what the Company has recorded in the current period.

The consolidated statements of operations for the three months ended April 2, 2011 and April 3, 2010 include the following stock-based compensation expense related to stock option awards, restricted stock, restricted stock unit awards and the employee stock purchase plan (in thousands):

		Three Months Ended
		April 2, 2011				April 3, 2010
Cost of sales		$	696			$	625
Selling and administrative expenses			5,466				4,657
Research and development expenses			853				749
Total stock-based compensation		$	7,015			$	6,031

As of both April 2, 2011 and December 31, 2010, the Company has capitalized stock-based compensation costs of less than $1 million in inventory in the consolidated balance sheets. As of both April 2, 2011 and December 31, 2010, the Company has capitalized stock-based compensation costs of $3 million in capitalized software in the consolidated balance sheets.

Stock Options

In determining the fair value of the stock options, the Company makes a variety of assumptions and estimates, including volatility measures, expected yields and expected stock option lives. The fair value of each option grant was estimated on the date of grant using the Black-Scholes option pricing model. The Company uses implied volatility on its publicly traded options as the basis for its estimate of expected volatility. The Company believes that implied volatility is the most appropriate indicator of expected volatility because it is generally reflective of historical volatility and expectations of how future volatility will differ from historical volatility. The expected life assumption for grants is based on historical experience for the population of non-qualified stock optionees. The risk-free interest rate is the yield currently available on U.S. Treasury zero-coupon issues with a remaining term approximating the expected term used as the input to the Black-Scholes model. The relevant data used to determine the value of the stock options granted during the three months ended April 2, 2011 and April 3, 2010 are as follows:

CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

Options Issued and Significant Assumptions Used to Estimate Option Fair Values		April 2, 2011				April 3, 2010
Options issued in thousands			32				32
Risk-free interest rate			2.1	%			3.0	%
Expected life in years			6				6
Expected volatility			0.290				0.293
Expected dividends			—				—
Weighted-Average Exercise Price and Fair Value of Options on the Date of Grant		April 2, 2011				April 3, 2010
Exercise price		$	78.10			$	61.63
Fair value		$	25.25			$	21.40

The following table summarizes stock option activity for the plans for the three months ended April 2, 2011 (in thousands, except per share data):

										Weighted-Average
		Number of Shares				Price per Share				Exercise Price
Outstanding at December 31, 2010			5,560			$21.39 to $80.97				$	50.19
Granted			32			$	78.10			$	78.10
Exercised			(334	)		$21.39 to $77.94				$	39.69
Canceled			(24	)		$36.25 to $80.97				$	80.87
Outstanding at April 2, 2011			5,234			$21.39 to $79.05				$	50.89

Restricted Stock

During the three months ended April 2, 2011, the Company granted twelve thousand shares of restricted stock. The fair value of these awards on the grant date was $78.10 per share. The restrictions on these shares lapse at the end of a three-year period.

Restricted Stock Units

The following table summarizes the unvested restricted stock unit award activity for the three months ended April 2, 2011 (in thousands, except for per share amounts):

		Shares				Weighted-Average Price
Unvested at December 31, 2010			752			$	49.64
Granted			173			$	79.00
Vested			(249	)		$	48.11
Forfeited			(3	)		$	52.62
Unvested at April 2, 2011			673			$	57.74

Restricted stock units are generally granted annually in February and vest in equal annual installments over a five-year period.

CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

7 Earnings Per Share

Basic and diluted earnings per share (“EPS”) calculations are detailed as follows (in thousands, except per share data):

		Three Months Ended April 2, 2011
						Weighted-Average
		Net Income				Shares				Per Share
		(Numerator)				(Denominator)				Amount
Net income per basic common share		$	94,489				91,649			$	1.03
Effect of dilutive stock option, restricted stock and restricted stock unit securities							1,664
Net income per diluted common share		$	94,489				93,313			$	1.01

		Three Months Ended April 3, 2010
						Weighted-Average
		Net Income				Shares				Per Share
		(Numerator)				(Denominator)				Amount
Net income per basic common share		$	75,518				93,629			$	0.81
Effect of dilutive stock option, restricted stock and restricted stock unit securities							1,594
Net income per diluted common share		$	75,518				95,223			$	0.79

For the three months ended April 2, 2011, the Company had 0.7 million stock options that were antidilutive due to having higher exercise prices than the Company’s average stock price during the period. For the three months ended April 3, 2010, the Company had 1.9 million stock options that were antidilutive. These securities were not included in the computation of diluted EPS. The effect of dilutive securities was calculated using the treasury stock method.

8 Comprehensive Income

Comprehensive income is detailed as follows (in thousands):

		Three Months Ended
		April 2,				April 3,
		2011				2010
Net income		$	94,489			$	75,518
Foreign currency translation			32,106				(23,410	)
Unrealized gains on investments before income taxes			2,488				41
Income tax expense			(871	)			(14	)
Unrealized gains on investments, net of tax			1,617				27
Retirement liability adjustment, net of tax			351				129
Other comprehensive income (loss)			34,074				(23,254	)
Comprehensive income		$	128,563			$	52,264

CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

9 Retirement Plans

The Company sponsors various retirement plans. The summary of the components of net periodic pension costs for the plans for the three months ended April 2, 2011 and April 3, 2010 is as follows (in thousands):

		Three Months Ended
		April 2, 2011												April 3, 2010
		U.S.				U.S. Retiree				Non-U.S.				U.S.				U.S. Retiree				Non-U.S.
		Pension				Healthcare				Pension				Pension				Healthcare				Pension
		Plans				Plan				Plans				Plans				Plan				Plans
Service cost		$	—			$	134			$	480			$	15			$	96			$	424
Interest cost			1,554				94				265				1,585				103				256
Expected return on plan assets			(1,880	)			(69	)			(75	)			(1,785	)			(53	)			(79	)
Net amortization:
Prior service credit			—				(13	)			—				—				(13	)			—
Net actuarial loss (gain)			433				—				7				262				—				(13	)
Net periodic pension cost		$	107			$	146			$	677			$	77			$	133			$	588

For the three months ended April 2, 2011, the Company contributed less than $1 million to the Company’s U.S. pension plans. During fiscal year 2011, the Company expects to contribute a total of approximately $4 million to $5 million to the Company’s defined benefit plans.

10 Business Segment Information

The Company’s business activities, for which discrete financial information is available, are regularly reviewed and evaluated by the chief operating decision makers. As a result of this evaluation, the Company determined that it has two operating segments: Waters Division and TA Division.

Waters Division is primarily in the business of designing, manufacturing, distributing and servicing LC and MS instruments, columns and other chemistry consumables that can be integrated and used along with other analytical instruments. TA Division is primarily in the business of designing, manufacturing, distributing and servicing thermal analysis, rheometry and calorimetry instruments. The Company’s two divisions are its operating segments and each has similar economic characteristics; product processes; products and services; types and classes of customers; methods of distribution and regulatory environments. Because of these similarities, the two segments have been aggregated into one reporting segment for financial statement purposes. Please refer to the consolidated financial statements for financial information regarding the one reportable segment of the Company.

Net sales for the Company’s products and services are as follows for the three months ended April 2, 2011 and April 3, 2010 (in thousands):

		Three Months Ended
		April 2, 2011				April 3, 2010
Product net sales:
Waters instrument systems		$	197,511			$	158,567
Chemistry			73,722				66,678
TA instrument systems			32,103				27,797
Total product sales			303,336				253,042
Service net sales:
Waters service			113,407				105,008
TA service			10,860				9,650
Total service sales			124,267				114,658
Total net sales		$	427,603			$	367,700

CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

11 Recent Accounting Standard Changes and Developments

Recently Adopted Accounting Standards

In October 2009, a new accounting consensus was issued for multiple-deliverable revenue arrangements. This consensus amends existing revenue recognition accounting standards. This consensus provides accounting principles and application guidance on whether multiple deliverables exist, how the arrangement should be separated and the consideration allocated. This guidance eliminates the requirement to establish the fair value of undelivered products and services and instead provides for separate revenue recognition based upon management’s estimate of the selling price for an undelivered item when there is no other means to determine the fair value of that undelivered item. Previously, the existing accounting consensus required that the fair value of the undelivered item be the price of the item either sold in a separate transaction between unrelated third parties or the price charged for each item when the item is sold separately by the vendor. Under the existing accounting consensus, if the fair value of all of the elements in the arrangement was not determinable, then revenue was deferred until all of the items were delivered or fair value was determined. This new approach is effective prospectively for revenue arrangements entered into or materially modified in fiscal years beginning on or after June 15, 2010. The adoption of this standard in the three months ended April 2, 2011 did not have a material effect on the Company’s financial position, results of operations or cash flows.

Also in October 2009, a new accounting consensus was issued for certain revenue arrangements that include software elements. This consensus amends the existing accounting guidance for revenue arrangements that contain tangible products and software. This consensus requires that tangible products which contain software components and non-software components that function together to deliver the tangible products essential functionality are no longer within the scope of the software revenue guidance. This new approach is effective prospectively for revenue arrangements entered into or materially modified in fiscal years beginning on or after June 15, 2010. The adoption of this standard in the three months ended April 2, 2011 did not have a material effect on the Company’s financial position, results of operations or cash flows.

Item 2: Management’s Discussion and Analysis of Financial Condition and Results of Operations

Business and Financial Overview

The Company has two operating segments: the Waters Division and the TA Division (“TA^®”). The Waters Division’s products and services primarily consist of high performance liquid chromatography (“HPLC”), ultra performance liquid chromatography (“UPLC^®” and together with HPLC, referred to as “LC”), mass spectrometry (“MS”) and chemistry consumable products and related services. TA products and services primarily consist of thermal analysis, rheometry and calorimetry instrument systems and service sales. The Company’s products are used by pharmaceutical, life science, biochemical, industrial, food safety, academic and government customers. These customers use the Company’s products to detect, identify, monitor and measure the chemical, physical and biological composition of materials and to predict the suitability of fine chemicals, polymers and viscous liquids in consumer goods and healthcare products.

The Company’s sales were $428 million and $368 million, an increase of 16% for the three months ended April 2, 2011 (the “2011 Quarter”) and April 3, 2010 (the “2010 Quarter”), respectively. In the 2011 Quarter, as compared with the 2010 Quarter, instrument system sales increased 23%, while new and recurring sales of chemistry consumables and services increased 9%. This overall increase in sales is attributable to increased spending by the Company’s pharmaceutical and industrial customers on LC, MS and TA products. The sales growth is also attributable to an increase in demand for the recently launched ACQUITY UPLC^® H-Class, Xevo^® Q-Tof^TM and Xevo^® TQ-S instrument systems, which had minimal sales in the 2010 Quarter. Sales growth of these new instrument systems was achieved in all major regions of the world. The effect of foreign currency translation increased sales by 2% in the 2011 Quarter.

During the 2011 Quarter, sales increased 22% in Asia (including Japan), 12% in Europe, 8% in the U.S. and 43% in the rest of the world as compared with the 2010 Quarter. The effect of foreign currency translation increased sales by 4% in Asia and by 3% in the rest of the world, while foreign currency translation did not impact European sales. The significant increase in sales in Asia for the 2011 Quarter is primarily due to continued strong sales growth in China and India. Japan’s sales grew 10% due to the effect of foreign currency translation. Japan’s sales have historically approximated 11% of the Company’s total annualized sales and, while the 2011 Quarter sales were in-line with the Company’s expectations, there can be no assurance that the recent disasters in Japan will not have a negative impact on the future sales, manufacturing supply-chain and the overall financial performance of the Company.

In the 2011 Quarter, sales to pharmaceutical customers increased 20% and combined sales to industrial and environmental customers increased 18% as compared with the 2010 Quarter. These increases were primarily a result of increased spending on instrument systems, chemistry consumables and services by the Company’s customers and the sales from the recently launched ACQUITY UPLC H-Class, Xevo Q-Tof and Xevo TQ-S instrument systems. Combined global sales to government and academic customers were 4% higher in the 2011 Quarter.

Operating income was $116 million and $92 million in the 2011 Quarter and 2010 Quarter, respectively. The overall increase in operating income in 2011 as compared to 2010 was primarily from the increases in sales volumes.

Net income per diluted share was $1.01 and $0.79 in the 2011 Quarter and 2010 Quarter, respectively. This increase in net income per diluted share was primarily attributable to the higher sales volume, the leveraging of the lower operating expense growth, lower weighted-average shares and equivalents and favorable foreign currency translation.

Net cash provided by operating activities was $123 million and $103 million in the 2011 Quarter and 2010 Quarter, respectively. The $20 million increase was primarily a result of higher net income in the 2011 Quarter. Net cash provided by operating activities was also impacted by the timing of receipts from customers and payments to vendors, as well as the payment of the 2010 management incentive plans.

Within cash flows used in investing activities, capital expenditures related to property, plant, equipment and software capitalization were $17 million and $10 million in the 2011 Quarter and 2010 Quarter, respectively.

Within cash flows used in financing activities, the Company received $14 million and $9 million of proceeds from stock plans in the 2011 Quarter and 2010 Quarter, respectively. Fluctuations in these amounts were primarily attributable to changes in the Company’s stock price and the expiration of stock option grants. In February 2011, the Company’s Board of Directors authorized the Company to repurchase up to $500 million of its outstanding common

stock over a two-year period. The Company repurchased $67 million and $101 million of the Company’s outstanding common stock in the 2011 Quarter and 2010 Quarter, respectively, under the February 2011 authorization and previously announced stock repurchase programs.

The Company issued and sold senior unsecured notes with a total face value of $200 million in both the 2011 Quarter and 2010 Quarter. The Company used the proceeds from the issuances of these senior unsecured notes to repay other outstanding debt and for general corporate purposes. As a result of these debt issuances, the Company’s weighted-average interest rates have increased in the 2011 Quarter due to higher rates paid on this fixed-rate debt.

Results of Operations

Net Sales

Product sales were $303 million and $253 million for the 2011 Quarter and the 2010 Quarter, respectively, an increase of 20%. The increase in product sales in the 2011 Quarter as compared to the 2010 Quarter was primarily due to higher demand from the Company’s pharmaceutical and industrial customers and the strong uptake in sales from the ACQUITY UPLC H-Class, Xevo Q-Tof and Xevo TQ-S instrument systems, which had minimal sales in the 2010 Quarter. Service sales were $124 million and $115 million in the 2011 Quarter and the 2010 Quarter, respectively, an increase of 8%. The increase in service sales in the 2011 Quarter as compared to the 2010 Quarter was primarily attributable to increased sales of service plans and billings to a higher installed base of customers.

Waters Division Sales

Waters Division sales increased 16% in the 2011 Quarter as compared to the 2010 Quarter. The effect of foreign currency translation impacted the Waters Division across all product lines, resulting in an increase in total sales of 2% in the 2011 Quarter.

Waters instrument system sales (LC and MS) increased 25% in the 2011 Quarter. The increase in instrument systems sales was primarily attributable to higher demand from the Company’s pharmaceutical, industrial, academic and government customers and the adoption and uptake in sales from the ACQUITY UPLC H-Class, Xevo Q-Tof and Xevo TQ-S instrument systems. Chemistry consumables sales increased 11% in the 2011 Quarter and were driven primarily by higher demand for chemistry consumable products, including increased sales of ACQUITY UPLC lines of columns. Waters Division service sales increased 8% in the 2011 Quarter due to increased sales of service plans and billings to a higher installed base of customers. Waters Division sales by product line in the 2011 Quarter were approximately 51% for instrument systems, 19% for chemistry consumables and 30% for service. Waters Division sales by product line in the 2010 Quarter were approximately 48% for instrument systems, 20% for chemistry consumables and 32% for service.

In the 2011 Quarter, as compared to the 2010 Quarter, the Waters Division sales in Asia increased 22%, Europe sales increased 12%, U.S. sales increased 9% and the rest of the world sales increased 43%. The increase in Asia’s sales is primarily due to strong sales growth in China and India. The effects of foreign currency translation increased Asia’s sales by 5% and the rest of world sales by 2% in the 2011 Quarter. The effects of foreign currency translation were neutral on the European sales.

TA Division Net Sales

TA’s sales were 15% higher in the 2011 Quarter as compared to the 2010 Quarter. The increase was primarily a result of higher demand for instrument systems from TA’s industrial customers due to improved economic conditions. Instrument system sales increased 15% in the 2011 Quarter and represented 75% of TA’s sales in the 2011 Quarter as compared to 74% in the 2010 Quarter. TA service sales increased 13% in the 2011 Quarter, primarily due to increased sales of service plans and billings to a higher installed base of customers. Geographically, TA’s sales increased in each territory.

Gross Profit

Gross profit for the 2011 Quarter was $258 million compared to $222 million for the 2010 Quarter, an increase of 16%. The increase in gross profit dollars in the 2011 Quarter can be primarily attributed to higher sales volumes. Gross profit as a percentage of sales was 60.3% in both the 2011 Quarter and 2010 Quarter as comparatively the positive effects of manufacturing cost reductions and sales volume leverage of fixed costs were offset by the unfavorable impact of foreign currency translation on manufacturing costs and a higher sales mix of instrument systems in the 2011 Quarter.

Selling and Administrative Expenses

Selling and administrative expenses for the 2011 Quarter and 2010 Quarter were $117 million and $107 million, respectively, an increase of 10%. This increase in selling and administrative expenses is a result of headcount additions; higher merit and fringe benefit costs; higher sales and incentive compensation costs; and foreign currency translation. As a percentage of net sales, selling and administrative expenses were 27.4% for the 2011 Quarter and 29.0% for the 2010 Quarter.

Research and Development Expenses

Research and development expenses were $22 million and $20 million for the 2011 Quarter and 2010 Quarter, respectively, an increase of 11%. The increase in research and development expenses in the 2011 Quarter was primarily due to development costs incurred on new products.

Provision for Income Taxes

The Company’s effective tax rate decreased to 16.0% in the 2011 Quarter from 16.2% in the 2010 Quarter. Included in the income tax provision for the 2010 Quarter is a $2 million tax benefit related to the resolution of a pre-acquisition tax exposure. This tax benefit decreased the Company’s effective tax rate by 1.7 percentage points in the 2010 Quarter. The remaining difference between the effective tax rates for the 2011 Quarter as compared to the 2010 Quarter was primarily attributable to differences in pre-tax income in jurisdictions with different effective tax rates.

The Company’s effective tax rate is influenced by many significant factors including, but not limited to, the wide range of income tax rates in jurisdictions in which the Company operates, sales volumes and profit levels in each tax jurisdiction, changes in tax laws and policies and the impact of foreign currency transactions and translation. As a result of variability in these factors, the Company’s effective tax rates in the future may not be similar to the effective tax rates in the 2011 Quarter or 2010 Quarter. A known factor that will increase the Company’s effective tax rate in the future is that the Company’s Ireland statutory tax rate has increased to 12.5% in 2011 from the historical contractual tax rate of 10%.

Liquidity and Capital Resources

Condensed Consolidated Statements of Cash Flows (in thousands):

		Three Months Ended
		April 2, 2011				April 3, 2010
Net income		$	94,489			$	75,518
Depreciation and amortization			16,160				14,985
Stock-based compensation			7,015				6,031
Deferred income taxes			(1,479	)			(1,950	)
Change in accounts receivable			17,730				(6,230	)
Change in inventories			(17,353	)			(16,134	)
Change in accounts payable and other current liabilities			(26,836	)			13,720
Change in deferred revenue and customer advances			23,856				23,732
Other changes			9,179				(6,517	)
Net cash provided by operating activities			122,761				103,155
Net cash used in investing activities			(121,107	)			(116,187	)
Net cash used in financing activities			(27,250	)			(18,479	)
Effect of exchange rate changes on cash and cash equivalents			13,958				(12,588	)
Decrease in cash and cash equivalents		$	(11,638	)		$	(44,099	)

Cash Flow from Operating Activities

Net cash provided by operating activities was $123 million and $103 million in the 2011 Quarter and 2010 Quarter, respectively. The changes within net cash provided by operating activities in the 2011 Quarter as compared to the 2010 Quarter include the following significant changes in the sources and uses of net cash provided by operating activities, aside from the increase in net income:

	•		The change in accounts receivable in the 2011 Quarter compared to the 2010 Quarter was primarily attributable to timing of shipments and payments made by customers and higher sales volumes in the 2011 Quarter as compared to the 2010 Quarter. Days-sales-outstanding (“DSO”) decreased to 74 days at April 2, 2011 from 78 days at April 3, 2010.
	•		The 2011 Quarter change in accounts payable and other current liabilities is a result of timing of payments to vendors and payments under the 2010 management incentive plans, offset somewhat by an increase in income taxes payable.
	•		Net cash provided from deferred revenue and customer advances in both the 2011 Quarter and the 2010 Quarter was a result of the installed base of customers renewing annual service contracts.
	•		Other changes were attributable to variation in the timing of various provisions, expenditures and accruals in other current assets, other assets and other liabilities.

Cash Used in Investing Activities

Net cash used in investing activities totaled $121 million and $116 million in the 2011 Quarter and 2010 Quarter, respectively. Additions to fixed assets and capitalized software were $17 million in the 2011 Quarter and $10 million in the 2010 Quarter.

During the 2011 Quarter and 2010 Quarter, the Company purchased $432 million and $217 million of short-term investments while $328 million and $111 million of short-term investments matured, respectively.

Cash Used in Financing Activities

The Company issued and sold senior unsecured notes with a total face value of $200 million in both the 2011 Quarter and 2010 Quarter. The Company used the proceeds from the issuance of these senior unsecured notes to repay $140 million of the term loan under the 2007 Credit Agreement and other outstanding debt, and for general corporate purposes. Interest on both issuances of senior unsecured notes is payable semi-annually. The Company may redeem some of the notes at any time in an amount not less than 10% of the aggregate principal amount outstanding, plus accrued and unpaid interest, plus the applicable make-whole amount. These notes require that the Company comply with an interest coverage ratio test of not less than 3.50:1 and a leverage ratio test of not more than 3.50:1 for any period of four consecutive fiscal quarters, respectively. In addition, these notes include customary negative covenants. These notes also contain certain customary representations and warranties, affirmative covenants and events of default.

During the 2011 Quarter and 2010 Quarter, the Company’s debt borrowings increased by $24 million and $81 million, respectively. As of April 2, 2011, the Company had $400 million in outstanding notes, $360 million borrowed under a term loan facility, $20 million borrowed under revolving credit facilities and $10 million borrowed under various other short-term lines of credit. In the 2011 Quarter, the entire outstanding balance of the 2007 Credit Agreement, which matures in January 2012, has been classified as a current liability in the consolidated balance sheet as of April 2, 2011. The Company anticipates refinancing the 2007 Credit Agreement at market interest rates and terms customary to investment-grade borrowers, but there can be no assurance that it will be able to do so on such terms. As of April 2, 2011, the Company had a total amount available to borrow under existing credit agreements of $579 million after outstanding letters of credit.

In February 2011, the Company’s Board of Directors authorized the Company to repurchase up to $500 million of its outstanding common stock over a two-year period. During the 2011 Quarter and 2010 Quarter, the Company repurchased a total of 0.9 million and 1.7 million shares at a cost of $67 million and $101 million, respectively, under the February 2011 authorization and previously announced programs. As of April 2, 2011, the Company had purchased an aggregate of 0.2 million shares at a cost of $17 million under the February 2011 program, leaving $483 million authorized for future repurchases.

The Company received $14 million and $9 million of proceeds from the exercise of stock options and the purchase of shares pursuant to the Company’s employee stock purchase plan in the 2011 Quarter and 2010 Quarter, respectively.

The Company believes that the cash, cash equivalents and short-term investments of $1,039 million at the end of the 2011 Quarter and expected cash flow from operating activities, together with borrowing capacity from committed credit facilities, will be sufficient to service debt and fund working capital and capital spending requirements, authorized share repurchase amounts, potential acquisitions and any adverse final determination of ongoing litigation for at least the next twelve months. Management believes, as of the date of this report, that its financial position, along with expected future cash flows from earnings based on historical trends and the ability to raise funds from external sources, will be sufficient to meet future operating and investing needs for the foreseeable future.

Contractual Obligations and Commercial Commitments

A summary of the Company’s contractual obligations and commercial commitments is included in the Company’s annual report on Form 10-K for the year ended December 31, 2010. The Company reviewed its contractual obligations and commercial commitments as of April 2, 2011 and determined that there were no material changes from the ones set forth in the Form 10-K, with the exception of the issuance of senior unsecured notes as described in Note 4, Debt, in the Condensed Notes to Consolidated Financial Statements.

From time to time, the Company and its subsidiaries are involved in various litigation matters arising in the ordinary course of business. The Company believes that it has meritorious arguments in its current litigation matters and that any outcome, either individually or in the aggregate, will not be material to the Company’s financial position or results of operations.

For the three months ended April 2, 2011, the Company contributed less than $1 million to the Company’s U.S. pension plans. During fiscal year 2011, the Company expects to contribute a total of approximately $4 million to $5 million to the Company’s defined benefit plans.

The Company has not paid any dividends and does not plan to pay any dividends in the foreseeable future.

Critical Accounting Policies and Estimates

In the Company’s annual report on Form 10-K for the year ended December 31, 2010, the Company’s most critical accounting policies and estimates upon which its financial status depends were identified as those relating to revenue recognition, loss provisions on accounts receivable and inventory, valuation of long-lived assets, intangible assets and goodwill, warranty, income taxes, pension and other postretirement benefit obligations, litigation and stock-based compensation. The Company reviewed its policies and determined that those policies remain the Company’s most critical accounting policies for the 2011 Quarter. The Company did not make any changes in those policies during the 2011 Quarter.

New Accounting Pronouncements

Refer to Note 11, Recent Accounting Standards Changes and Developments, in the Condensed Notes to Consolidated Financial Statements.

Special Note Regarding Forward-Looking Statements

Certain of the statements in this quarterly report on Form 10-Q, including the information incorporated by reference herein, may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), with respect to future results and events, including statements regarding, among other items, anticipated trends in the Company’s business; geographic breakdown of business; anticipated expenses, including interest expense and amortization expense; the impact of the Company’s various ongoing tax audits and litigation matters; the impact of the loss of intellectual property protection; the effect of new accounting pronouncements; use of the Company’s debt proceeds; the impact of regulatory compliance; the Company’s expected cash flow, borrowing capacity and debt refinancing; the Company’s contributions to defined benefit plans; the Company’s expectations regarding the payment of dividends; and the Company’s capital spending, sufficiency of capital and ability to fund other facility expansions to accommodate future sales growth.

Many of these statements appear, in particular, under the heading “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in Part I, Item 2 of this quarterly report on Form 10-Q. Statements that are not statements of historical fact may be deemed forward-looking statements. You can identify these forward-looking statements by the use of the words “believes”, “anticipates”, “plans”, “expects”, “may”, “will”, “would”, “intends”, “appears”, “estimates”, “projects”, “should” and similar expressions, whether in the negative or affirmative. These statements are subject to various risks and uncertainties, many of which are outside the control of the Company, including, and without limitation:

•		Current economic conditions and uncertainties; ability to access capital in volatile market conditions; changes in demand by the Company’s customers and various market sectors, particularly if they should reduce capital expenditures; the effect of mergers and acquisitions on customer demand; and ability to sustain and enhance service; the potential negative financial impact of the Japan disasters on customer demand.
•		Negative industry trends; introduction of competing products by other companies and loss of market share; pressures on prices from customers or resulting from competition; regulatory, economic and competitive obstacles to new product introductions; lack of acceptance of new products; expansion of our business in Asia; spending by certain end-markets and ability to obtain alternative sources for components and modules.
•		Foreign exchange rate fluctuations that could adversely affect translation of the Company’s future financial operating results and condition.
•		Increased regulatory burdens as the Company’s business evolves, especially with respect to the U.S. Securities and Exchange Commission, U.S. Food and Drug Administration, and U.S. Environmental Protection Agency, among others and regulatory, environmental and logistical obstacles affecting the distribution of the Company’s products and completion of purchase order documentation.
•		Risks associated with lawsuits, particularly involving claims for infringement of patents and other intellectual property rights.
•		The impact and costs incurred from changes in accounting principles and practices or tax rates (specifically, the increase in the Company’s 2011 statutory tax rate in Ireland from the 10% historical contractual tax rate to 12.5%); shifts in taxable income in jurisdictions with different effective tax rates; and the outcome of and costs associated with ongoing and future tax examinations or changes in respective country legislation affecting the Company’s effective rates.

Certain of these and other factors are discussed in Part II, Item 1A of this quarterly report on Form 10-Q and under the heading “Risk Factors” under Part I, Item 1A of the Company’s annual report on Form 10-K for the year ended December 31, 2010. Actual results or events could differ materially from the plans, intentions and expectations disclosed in the forward-looking statements, whether because of these factors or for other reasons. All forward-looking statements speak only as of the date of this quarterly report on Form 10-Q and are expressly qualified in their entirety by the cautionary statements included in this report. Except as required by law, the Company does not assume any obligation to update any forward-looking statements.

Item 3: Quantitative and Qualitative Disclosures About Market Risk

There has been no material change in the Company’s market risk during the three months ended April 2, 2011. For information regarding the Company’s market risk, refer to Item 7A of Part II of the Company’s annual report on Form 10-K for the year ended December 31, 2010, as filed with the Securities and Exchange Commission (“SEC”) on February 25, 2011.

Item 4: Controls and Procedures

Evaluation of Disclosure Controls and Procedures

The Company’s chief executive officer and chief financial officer (principal executive and principal financial officer), with the participation of management, evaluated the effectiveness of the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of the end of the period covered by this quarterly report on Form 10-Q. Based on this evaluation, the Company’s chief executive officer and chief financial officer concluded that the Company’s disclosure controls and procedures were effective as of April 2, 2011 (1) to ensure that information required to be disclosed by the Company, including its consolidated subsidiaries,

in the reports that it files or submits under the Exchange Act is accumulated and communicated to the Company’s management, including its chief executive officer and chief financial officer, to allow timely decisions regarding the required disclosure and (2) to provide reasonable assurance that information required to be disclosed by the Company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms.

Changes in Internal Controls Over Financial Reporting

There have been no changes identified in the Company’s internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the quarter ended April 2, 2011 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

Part II: Other Information

Item 1: Legal Proceedings

There have been no material changes in the Company’s legal proceedings during the three months ended April 2, 2011 as described in Item 3 of Part I of the Company’s annual report on Form 10-K for the year ended December 31, 2010, as filed with the SEC on February 25, 2011.

Item 1A: Risk Factors

Information regarding risk factors of the Company is set forth under the heading “Risk Factors” under Part I, Item 1A in the Company’s annual report on Form 10-K for the year ended December 31, 2010. The Company reviewed its risk factors as of April 2, 2011 and determined that there were no material changes from the ones set forth in the form 10-K, except as reflected under “Special Note Regarding Forward-Looking Statements” on page 19, in particular, as to the possible negative effect on demand from Japanese customers from the recent Japan disasters. These risks are not the only ones facing the Company. Additional risks and uncertainties not currently known to the Company or that the Company currently deems to be immaterial also may materially adversely affect the Company’s business, financial condition and its operating results.

Item 2: Unregistered Sales of Equity Securities and Use of Proceeds

Purchases of Equity Securities by the Issuer

The following table provides information about purchases by the Company during the three months ended April 2, 2011 of equity securities registered by the Company under the Exchange Act (in thousands, except per share data):

										Total Number of				Maximum Dollar
										Shares Purchased as				Value of Shares
										Part of Publicly				that May Yet Be
		Total Number of				Average Price Paid				Announced Plans or				Purchased Under the
Period		Shares Purchased				per Share				Programs (1) (2)				Plans or Programs
January 1 to January 29, 2011			50			$	75.98				50			$	47,364
January 30 to February 26, 2011			600			$	77.41				600			$	500,000
February 27 to April 2, 2011			197			$	84.66				197			$	483,322
Total			847			$	79.01				847			$	483,322

Item 6: Exhibits

Exhibit
Number		Description of Document
10.62		Note Purchase Agreement, dated March 15, 2011 between Waters Corporation and the purchasers named therein.
10.63		First Amendment to the Note Purchase Agreement Dated as of February 2, 2010.
31.1		Chief Executive Officer Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2		Chief Financial Officer Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1 **		Chief Executive Officer Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2 **		Chief Financial Officer Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101 **		The following materials from Waters Corporation’s Quarterly Report on Form 10-Q for the quarter ended April 2, 2011, formatted in XBRL (Extensible Business Reporting Language): (i) the Consolidated Balance Sheets, (ii) the Consolidated Statements of Operations, (iii) the Consolidated Statements of Cash Flows, and (iv) Condensed Notes to Consolidated Financial Statements.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: May 6, 2011